Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2251 to 2265 of 8314 results

  1. Talazoparib with enzalutamide for untreated hormone-sensitive metastatic prostate cancer with a homologous recombination repair mutation [ID6460]

    Awaiting development Reference number: GID-TA11534 Expected publication date: TBC

  2. Lenacapavir for treating multidrug resistant HIV-1 [ID6196]

    Topic prioritisation

  3. MT633 FreeO2 Automatic Oxygen Titration

    Topic prioritisation

  4. MT656 Paige Prostate AI system for the detection of prostate cancer

    Topic prioritisation

  5. MT660 CerebAir for monitoring continuous, real-time EEG

    Topic prioritisation

  6. MT658 Quit Genius for Smoking Cessation

    Topic prioritisation

  7. MT684 Smart Peak Flow for monitoring asthma

    Topic prioritisation

  8. The Insides System chyme reinfusion system (MT682)

    Topic prioritisation

  9. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

  10. Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687)

    Topic prioritisation

  11. RespiraSense (MT736)

    Topic prioritisation

  12. Signatera molecular residual disease assay (MT741)

    Topic prioritisation

  13. Stockholm3 blood test for prostate cancer, (MT734),

    Topic prioritisation

  14. PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740)

    Topic prioritisation

  15. Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)

    Topic prioritisation